Dermatomyositis Completed Phase 2 / 3 Trials for Anakinra (DB00026)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01165008Anakinra in MyositisTreatment